Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2022-09-07 Legal Proceedings Report
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Bijzonder verslag commissaris overeenk. art. 7198 juncto Art. 7179 en 7197 WVV.pdf
Legal Proceedings Report Classification · 99% confidence The document is titled 'Verslag van de commissaris aan de raad van bestuur inzake de inbreng in natura (artikel 7:197 WVV) en de uitgifte van aandelen (artikel 7:179 WVV)' which translates to 'Report of the commissioner to the board of directors regarding the contribution in kind (Article 7:197 WVV) and the issuance of shares (Article 7:179 WVV)'. The text extensively discusses the legal framework (WVV articles), the appointment of the commissioner, the identification of parties involved in a capital increase via contribution in kind (inbreng in natura) related to a recapitalization transaction, and the conclusion regarding the fairness of the valuation. This structure and content strongly indicate a formal statutory report required for a capital transaction involving non-cash assets (contribution in kind) under Belgian corporate law (WVV). This aligns best with the 'Audit Report / Information' (AR) category, as it is a formal report by an appointed commissioner/auditor concerning a specific financial/statutory transaction, distinct from a full Annual Report (10-K) or a general Interim Report (IR). It is a specific statutory report on a transaction.
2022-09-07 Dutch
Special board report Art. 7198 juncto Art. 7179 and 7197 BCCA.pdf
Management Reports Classification · 99% confidence The document is explicitly titled 'REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLE 7:198 JUNCTO ARTICLES 7:179 AND 7:197 OF THE BELGIAN COMPANIES AND ASSOCIATIONS CODE'. This structure, detailing a proposed capital increase via a contribution in kind (issuance of shares for debt settlement), is characteristic of a formal corporate action disclosure required under Belgian law, often presented to shareholders for approval or information. Specifically, it discusses the issuance of shares (a capital change) in consideration for settling a commitment fee receivable, which falls under capital structure changes. While it involves share issuance (SHA) and is a formal report, the core purpose described—justifying a capital increase and contribution in kind under specific legal articles—aligns closely with documents related to capital structure changes and formal corporate governance disclosures. Given the detailed justification of the capital increase and the nature of the transaction (issuance of shares for debt settlement), the most fitting category is 'Capital/Financing Update' (CAP), as it directly concerns the company's capital structure change. It is not a general Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). It is a comprehensive report justifying a specific capital action.
2022-09-07 English
Bijzonder verslag raad van bestuur art. 7198 juncto Art. 7179 en 7197 WVV.pdf
Capital/Financing Update Classification · 95% confidence The document is titled "VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:198 *JUNCTO* DE ARTIKELEN 7:179 EN 7:197 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Report of the Board of Directors pursuant to Article 7:198 *juncto* Articles 7:179 and 7:197 of the Companies and Associations Code). This structure strongly indicates a formal report prepared by the Board of Directors to justify a specific corporate action to shareholders, which aligns with Belgian corporate governance reporting requirements. The content explicitly details a proposed capital increase via a contribution in kind (inbreng in natura) to settle a commitment fee (Backstop Toezeggingsvergoeding) owed to lenders (Kredietgevers) as part of a broader recapitalization plan. The document justifies the transaction, the issue price, and the impact on shareholders, referencing specific articles (7:179 and 7:197) that mandate such justification reports. This is not a standard Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). It is a comprehensive report detailing a significant capital structure change and the rationale behind it, prepared for shareholder approval or information, which fits best under the general category of corporate governance or specific financing documentation. Given the options, the document describes a specific corporate action (capital increase via contribution in kind) and the required board report justifying it. While it relates to financing (CAP), the document *is* the formal Board Report justifying the capital change, not just the announcement of the financing itself. In the context of Belgian corporate law filings, a report detailing the justification for a capital increase by contribution in kind, as mandated by specific articles of the Companies Code, is a specialized report. Since there isn't a perfect fit for 'Report on Capital Increase Justification', we must evaluate the closest options. It is a detailed report explaining management's view on a transaction, which is similar to Management Discussion & Analysis (MDA), but the primary focus is the legal justification for a capital change. The closest fit among the provided codes for a detailed report justifying a major corporate action involving capital structure, especially when it involves in-kind contributions and is mandated by corporate law articles, is often related to governance or specific financing disclosures. However, since the core purpose is to justify a capital structure change (issuing shares for debt settlement/fee), 'Capital/Financing Update' (CAP) is plausible, but the document *is* the formal report itself, not just an announcement. Given the detailed legal justification required by the Belgian Code, this document functions as a highly specific disclosure document. Since it is a formal report detailing the rationale for a capital transaction, and it is not a standard 10-K or IR, it is most closely related to the underlying financing activity being disclosed. However, looking closely at the definitions, 'CAP' is for 'Updates on company fundraising, financing activities, or capital structure changes.' This document is the formal report *about* that change. If we consider the nature of the report (a formal justification required by law for a capital change), it is a highly specific disclosure. Given the options, and recognizing it is a formal report detailing a capital structure change, 'CAP' is the most relevant category for the subject matter, although 'AR' (Audit Report/Information) or 'RPA' (Report Publication Announcement) might be considered if it were just an announcement. Since it is the full report justifying the capital change, 'CAP' captures the essence of the content better than the fallback 'RNS'. I will classify it as CAP, as it is the detailed report justifying the capital structure change.
2022-09-07 Dutch
220906 PR Outstanding Shares_ENG_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly labeled as a 'PRESS RELEASE REGULATED INFORMATION' dated September 6, 2022. The core content is the 'DISCLOSURE OF OUTSTANDING VOTING SECURITIES' following the issuance of new shares related to a recapitalization. It details the total outstanding share capital, voting securities, and potential future issuances, referencing Belgian disclosure laws (Article 15 of the Belgian Act of 2 May 2007). This type of announcement, which discloses changes in the total number of shares and voting rights, directly relates to capital structure changes and major shareholding notifications, but the primary focus here is the formal disclosure of the total share count resulting from a transaction. Since the document announces the issuance of shares to settle a fee ('Share Issue/Capital Change' - SHA) and simultaneously discloses the resulting total voting rights (which is related to 'Major Shareholding Notification' - MRQ thresholds), the most fitting category that captures the immediate action and disclosure of the resulting share count is related to capital changes or major shareholding updates. Given the context of issuing shares and immediately calculating the new total outstanding voting securities as required by law, 'SHA' (Share Issue/Capital Change) is highly relevant, as is 'MRQ' (Major Shareholding Notification, as the disclosure is tied to thresholds). However, the document is a formal press release announcing the result of a capital transaction (issuance of 810,734 new shares) and the resulting total share count. This fits best under 'SHA' (Share Issue/Capital Change) or potentially 'RNS' (General Regulatory Filing) if it were purely informational. Since it details the issuance of new shares and the resulting capital structure, 'SHA' is the most specific fit among the primary options. If it were purely a notification that a threshold was crossed by an external party, it would be MRQ. Since the company is announcing the issuance itself, SHA is appropriate. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific regulatory disclosure event.
2022-09-06 English
220906 PR Outstanding Shares_NL_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled 'PERSBERICHT GEREGLEMENTEERDE INFORMATIE' (Regulated Information Press Release) and its primary content is the 'OPENBAARMAKING VAN UITSTAANDE STEMRECHTVERLENENDE EFFECTEN' (Disclosure of Outstanding Voting Rights Securities). It details the issuance of new shares to creditors as part of a recapitalization and updates the total outstanding capital and voting rights, referencing Belgian disclosure laws (Wet van 2 mei 2007). This type of mandatory disclosure regarding changes in the capital structure and total voting rights, often triggered by specific transactions or regulatory requirements, fits best under 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS). Since the core subject is the issuance of shares and the resulting change in the total number of securities outstanding, CAP is the most specific fit, as it relates directly to capital structure changes resulting from financing activities (settling debt with equity). It is not a general earnings release (ER), an interim report (IR), or a formal annual report (10-K).
2022-09-06 Dutch
220831 PR Refinancing_ENG_FINAL.pdf
Capital/Financing Update Classification · 98% confidence The document is explicitly labeled as a "PRESS RELEASE REGULATED INFORMATION/INSIDE INFORMATION" dated 1 September 2022. The content details a "comprehensive recapitalization transaction" involving deleveraging, maturity extension of convertible bonds, a rights issue, and new term loans. This announcement concerns significant changes to the company's capital structure and financing activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific, major financial event.
2022-09-01 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.